ATE269088T1 - Tixocortolpivalathaltige pharmazeutische suspension,daraus hergestelltes mundwasser und diese suspension enthaltende verpackung - Google Patents

Tixocortolpivalathaltige pharmazeutische suspension,daraus hergestelltes mundwasser und diese suspension enthaltende verpackung

Info

Publication number
ATE269088T1
ATE269088T1 AT00949689T AT00949689T ATE269088T1 AT E269088 T1 ATE269088 T1 AT E269088T1 AT 00949689 T AT00949689 T AT 00949689T AT 00949689 T AT00949689 T AT 00949689T AT E269088 T1 ATE269088 T1 AT E269088T1
Authority
AT
Austria
Prior art keywords
suspension
pivate
tixocortol
produced therefrom
packaging
Prior art date
Application number
AT00949689T
Other languages
English (en)
Inventor
Bernard Doat
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Application granted granted Critical
Publication of ATE269088T1 publication Critical patent/ATE269088T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Communicable Diseases (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Dispersion Chemistry (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Cartons (AREA)
  • Detergent Compositions (AREA)
  • Supplying Of Containers To The Packaging Station (AREA)
  • Control And Other Processes For Unpacking Of Materials (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Polymerisation Methods In General (AREA)
  • Display Devices Of Pinball Game Machines (AREA)
  • Wrapping Of Specific Fragile Articles (AREA)
  • Vehicle Body Suspensions (AREA)
AT00949689T 1999-07-22 2000-07-07 Tixocortolpivalathaltige pharmazeutische suspension,daraus hergestelltes mundwasser und diese suspension enthaltende verpackung ATE269088T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9909556A FR2796553B1 (fr) 1999-07-22 1999-07-22 Suspension de tixocortol pivalate, collutoire a base de celle-ci et conditionnement la contenant
PCT/FR2000/001987 WO2001007053A1 (fr) 1999-07-22 2000-07-07 Suspension de tixocortol pivalate, collutoire a base de celle-ci et conditionnement la contenant

Publications (1)

Publication Number Publication Date
ATE269088T1 true ATE269088T1 (de) 2004-07-15

Family

ID=9548429

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00949689T ATE269088T1 (de) 1999-07-22 2000-07-07 Tixocortolpivalathaltige pharmazeutische suspension,daraus hergestelltes mundwasser und diese suspension enthaltende verpackung

Country Status (25)

Country Link
EP (1) EP1200096B1 (de)
JP (1) JP2003505421A (de)
KR (1) KR100718211B1 (de)
AT (1) ATE269088T1 (de)
AU (1) AU6296700A (de)
BG (1) BG106358A (de)
BR (1) BR0012671A (de)
CA (1) CA2378390C (de)
CZ (1) CZ2002144A3 (de)
DE (1) DE60011620T2 (de)
DK (1) DK1200096T3 (de)
DZ (1) DZ3207A1 (de)
EE (1) EE200200039A (de)
ES (1) ES2219366T3 (de)
FR (1) FR2796553B1 (de)
HK (1) HK1046850B (de)
HU (1) HUP0202055A3 (de)
IS (1) IS6228A (de)
MX (1) MXPA02000834A (de)
NO (1) NO20020252L (de)
OA (1) OA11993A (de)
PL (1) PL354100A1 (de)
PT (1) PT1200096E (de)
SK (1) SK762002A3 (de)
WO (1) WO2001007053A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5317512B2 (ja) * 2008-03-31 2013-10-16 小林製薬株式会社 含嗽用組成物
JP5461785B2 (ja) * 2008-03-31 2014-04-02 小林製薬株式会社 繰り返し感染予防用の医薬組成物
JP2013123450A (ja) * 2011-12-13 2013-06-24 Akihiro Sato 金属錯体イオン液を応用した塵肺の療養方法、および、咽頭・気管・気管支の療養方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4877781A (en) * 1987-09-30 1989-10-31 Peter G. LaHaye Medical dispenser and preparation for inflamed tissue
US5540930A (en) * 1993-10-25 1996-07-30 Pharmos Corporation Suspension of loteprednol etabonate for ear, eye, or nose treatment
WO1997020578A1 (en) * 1995-12-04 1997-06-12 University Of Miami Non-preserved topical corticosteroid for treatment of dry eye, filamentary keratitis, and delayed tear clearance

Also Published As

Publication number Publication date
MXPA02000834A (es) 2003-07-14
OA11993A (fr) 2006-04-18
DE60011620T2 (de) 2005-07-21
DK1200096T3 (da) 2004-09-13
HUP0202055A2 (en) 2002-09-28
EP1200096B1 (de) 2004-06-16
HK1046850B (zh) 2004-12-31
DZ3207A1 (fr) 2001-02-01
WO2001007053A1 (fr) 2001-02-01
CA2378390A1 (en) 2001-02-01
ES2219366T3 (es) 2004-12-01
DE60011620D1 (de) 2004-07-22
AU6296700A (en) 2001-02-13
HK1046850A1 (en) 2003-01-30
KR20020012010A (ko) 2002-02-09
JP2003505421A (ja) 2003-02-12
NO20020252D0 (no) 2002-01-17
BR0012671A (pt) 2002-04-09
SK762002A3 (en) 2002-08-06
PL354100A1 (en) 2003-12-29
FR2796553B1 (fr) 2001-09-28
BG106358A (bg) 2002-08-30
EE200200039A (et) 2003-04-15
HUP0202055A3 (en) 2009-03-30
FR2796553A1 (fr) 2001-01-26
IS6228A (is) 2002-01-15
EP1200096A1 (de) 2002-05-02
KR100718211B1 (ko) 2007-05-15
CZ2002144A3 (cs) 2002-06-12
PT1200096E (pt) 2004-10-29
NO20020252L (no) 2002-01-17
CA2378390C (en) 2008-09-23

Similar Documents

Publication Publication Date Title
BR9801652A (pt) Resorcinil-triazinas
DE60138948D1 (de) Medizinische aerosolformulierung von antidiabetika
BR0007147A (pt) Composição de tensìdio contendo tensìdio gemini e co-anfifila, sua preparação e aplicação
ATE478841T1 (de) Azetidinderivate enthaltende pharmazeutische zusammensetzungen, die azetidinderivate und deren herstellung
DE69931930D1 (de) Verbindungen und zusammensetzungen zur verabreichung aktiven substanzen
DE60003863D1 (de) Dioxocyclopentylhydroxamsäure
BR9810495A (pt) Composição farmacêutica
IL142066A0 (en) Arylsulfonanilide urea derivatives and pharmaceutical compositions containing the same
EE05091B1 (et) Oligosahhariidid, nende valmistamismeetod ja kasutamine ning farmatseutilised kompositsioonid
TNSN04034A1 (en) Combined preparations, containing 1,4-benzothiepine-1,1-dioxide derivatives and other active substances, and the use thereof
PT896533E (pt) Pentafluorobenzenosulfonamidas e analogos
MA26303A1 (fr) Compositions comprenant des resines organosiloxanes pour administration orale de substances de soins.
BR9909357A (pt) Solução ou suspensão de mirtazapina em mistura com água, formulação farmacêutica compreendendo mirtazapina, e, uso de mirtazapina
DE60128100D1 (de) Analgetisches arzneimittel
DE60121048D1 (de) PYRAZINOi1'2':1,6öPYRIDOi3,4-BöINDOLDERIVATE
DE60011620D1 (de) Tixocortolpivalathaltige pharmazeutische suspension,daraus hergestelltes mundwasser und diese suspension enthaltende verpackung
BR0206960A (pt) Composição farmacêutica oral, e, uso de um polìmero de ftalato de hidroxipropilmetilcelulose
BR9910454A (pt) Preparações efervescentes
ATE408619T1 (de) Lh-rh-antagonisten, deren herstellung und verwendung als arzneimittel
DE60005517D1 (de) Kaliumkanal-blockierende mittel
GEP20043225B (en) 1-Trifluoromethyl-4-Hydroxy-7- Piperidinyl-Aminomethylchroman Derivatives
TR200001122T2 (tr) Farmasötikler olarak bifenil türevleri.
DE60010230D1 (de) Pharmazeutische zusammensetzung von hydrophob modifizierten hedgehog-proteinen und deren verwendung
MD1473G2 (ro) Remediu antiherpetic
ID27656A (id) Turunan azabisikloheptana n-tersubstitusi, pembuatan dan penggunaannya

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1200096

Country of ref document: EP

REN Ceased due to non-payment of the annual fee